TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions May 6, 1983
TCL Archive New Design For NCI’s CancerNet Wins Prestigious Web Site Design Awards. November 17, 2000
